Fluticasone furoate
- Generic Name
- Fluticasone furoate
- Brand Names
- Arnuity Ellipta, Avamys, Breo Ellipta, Flonase Sensimist, Trelegy Ellipta, Veramyst
- Drug Type
- Small Molecule
- Chemical Formula
- C27H29F3O6S
- CAS Number
- 397864-44-7
- Unique Ingredient Identifier
- JS86977WNV
- Background
Fluticasone furoate is a synthetic glucocorticoid available as an inhaler and nasal spray for various inflammatory indications. Fluticasone furoate was first approved in 2007.
- Indication
Fluticasone furoate is indicated for once-daily maintenance (i.e. prophylactic) treatment of asthma in patients ≥5 years old. Fluticasone furoate is available in two combination medications - one in combination with vilanterol and one in combination with both vilanterol and umeclidinium- which are both indicated for the management of chronic obstructive pulmonary disease (COPD) and for the treatment of asthma in patients ≥18 years old for the vilanterol-umeclidinium-fluticasone product and ≥5 years old for the vilanterol-fluticasone product.
Fluticasone furoate is available over the counter as a nasal spray for the symptomatic treatment of hay fever and other upper respiratory allergies in patients ≥2 years old.
- Associated Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Perennial Allergy, Seasonal Allergies
Study Of Adults And Adolescents With Vasomotor Rhinitis
- First Posted Date
- 2005-07-06
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 352
- Registration Number
- NCT00117325
- Locations
- 🇷🇴
GSK Investigational Site, Deva, Romania
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
- Conditions
- HayfeverRhinitis, Allergic, SeasonalSeasonal Allergic Rhinitis
- First Posted Date
- 2005-06-24
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 304
- Registration Number
- NCT00115622
- Locations
- 🇺🇸
GSK Investigational Site, San Antonio, Texas, United States
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
- First Posted Date
- 2005-04-29
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 56
- Registration Number
- NCT00109486
- Locations
- 🇩🇰
GSK Investigational Site, Randers, Denmark
Perennial Allergic Rhinitis Study In Pediatric Subjects
- Conditions
- Rhinitis, Allergic, Perennial
- First Posted Date
- 2005-04-21
- Last Posted Date
- 2017-01-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 558
- Registration Number
- NCT00108914
- Locations
- 🇸🇰
GSK Investigational Site, Nitra, Slovakia
Seasonal Allergic Rhinitis In Pediatric Subjects
- Conditions
- Rhinitis, Allergic, Perennial
- First Posted Date
- 2005-04-08
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 576
- Registration Number
- NCT00107757
- Locations
- 🇺🇸
GSK Investigational Site, Madison, Wisconsin, United States
A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).
- First Posted Date
- 2005-02-09
- Last Posted Date
- 2016-09-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 288
- Registration Number
- NCT00103454
- Locations
- 🇨🇦
GSK Investigational Site, Saskatoon, Saskatchewan, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.